...
首页> 外文期刊>The Internet Journal of Health >Histological Studies Of The Effects Of Oral Administration Of Artesunate On The Stomach Of Adult Wistar Rats
【24h】

Histological Studies Of The Effects Of Oral Administration Of Artesunate On The Stomach Of Adult Wistar Rats

机译:青蒿琥酯口服对成年Wistar大鼠胃部影响的组织学研究

获取原文
           

摘要

The histological effect of oral administration of artesunate commonly used for the treatment of Malaria on the stomach of adult Wistar rat was carefully studied. The rats of both sexes (n=24), average weight of 210g were randomly assigned into three treatment (n=18) and control (n=6) groups. The rats in the treatment group 'A' received 4mg/kg body weight of artesunate base dissolved in distilled water daily for 3 days, through orogastric tube. The animals in groups 'B' and 'C' received 4mg/kg body weight of artesunate base dissolved in distilled water for the first day and thereafter received 2mg/kg body weight daily for six and thirteen days through the same route respectively, while that of the control group D, received equal volume of distilled water daily during the period of the experiment. The rats were fed with growers' mash obtained from Edo Feeds and Flour Mill Ltd, Ewu, Edo State, Nigeria and were given water liberally. The rats were sacrificed on day four, eight and fifteen of the experiment. The stomach was carefully dissected out and quickly fixed in 10% formal saline for histological studies. The histological findings after H&E method indicated that the treated section of the stomach showed some degenerative and necrotic changes, cellular hypertrophy, and increase intercellular vacuolations appearing in the stroma of the stomach of adult Wistar rats. Varying dosage and long administration of artesunate may have some deleterious effects on the gastric cells and stomach mucosa, and this may probably have some adverse effects like gastritis or worse still gastric ulcer in adult Wistar rats. It is therefore recommended that further studies aimed at corroborating these observations be carried out. Introduction Malaria remains one of the world's most significant health problems despite increasing research and control efforts1. Over two billion people are at risk of infection, over a quarter of a billion cases are thought to occur annually, and at least a million people die every year as a result of the disease, alone or in combination with other conditions. The disease is estimated to be responsible for an annual loss of around 0.5 to 1% of gross domestic product in countries where it is endemic2. The occurrence of malaria during pregnancy exposes the mother and infants to serious risks. It is therefore imperative that pregnant women be protected against malaria; and that pregnant women with malaria receive treatment as soon as possible3. Artesunate is one of the numerous drugs for malaria intervention in Nigeria. It is a semi synthetic derivative of artemisinin, the active compound of the Chinese herb Artemisia annua which consist of the sodium succinyl salt of dehyroartemisinin3. Artemisinin-type compounds reduce malaria parasitemia more rapidly than any other known antimalarial drugs and are effective against multi drug resistant malaria parasites4,5. Artesunate is highly effective against multi-drug resistant strains of plasmodium falciparum hence its increasingly wide usage for the treatment and management of malaria6. Artesunate is well tolerated at therapeutic doses; therefore a lot of people, pregnant women inclusive take the drug. Several studies have shown that high doses of artesunate can produce neurotoxicity such as selective damage to brainstem centres in mice and rats7,8,9. Artesunate have been reported to cause gait disturbances, loss of spinal cord and pain response mechanisms in animals10,11.The stomach, a distensible organ located in the abdominal cavity, functions in the degradation and digestion of food materials in the body. It also prevents gastric ulceration due to the presence of numerous mucous secreting glands12. The effects of artesunate on the stomach may not have been documented, but there have been reports that it may be implicated in varied symptoms of nausea, vomiting, diarrhea and abdominal pain. This present study was to elucidate the histological effects of artesunate on the stomach
机译:仔细研究了通常用于治疗疟疾的青蒿琥酯口服液对成年Wistar大鼠胃部的组织学作用。性别(n = 24),平均体重210g的大鼠随机分为3组(n = 18)和对照组(n = 6)。治疗组“ A”的大鼠通过口胃管每天接受4mg / kg体重的青蒿琥酯碱溶解在蒸馏水中,持续3天。 “ B”和“ C”组中的动物在第一天接受溶于蒸馏水中的青蒿琥酯碱4mg / kg体重,此后通过相同途径分别接受六天和十三天的2mg / kg体重,而在实验期间,对照组D每天接受等量的蒸馏水。给老鼠喂食从尼日利亚的伊多州伊武市的Edo Feeds and Flour Mill Ltd生产的grow子,并自由饮水。在实验的第四,八和十五天处死大鼠。仔细解剖胃并快速固定在10%的生理盐水中以进行组织学研究。 H&E方法后的组织学结果表明,成年Wistar大鼠胃的被处理部分显示出一些变性和坏死性变化,细胞肥大和增加的细胞间空泡。青蒿琥酯的不同剂量和长期服用可能对胃细胞和胃粘膜有一些有害作用,并且可能对成年Wistar大鼠产生某些不利影响,如胃炎或更严重的胃溃疡。因此,建议进行进一步的研究以证实这些观察结果。引言尽管加大了研究和控制力度,疟疾仍然是世界上最严重的健康问题之一。超过20亿人处于感染的危险中,据认为每年发生的病例超过10亿的四分之一,并且每年至少有100万人死于该疾病,无论是单独还是与其他条件相结合。据估计,这种疾病在地方病流行的国家造成的年度损失约为国内生产总值的0.5%至1%2。怀孕期间发生疟疾使母亲和婴儿面临严重的风险。因此,必须保护孕妇免受疟疾的侵害;疟疾孕妇应尽快接受治疗3。青蒿琥酯是尼日利亚多种用于疟疾干预的药物之一。它是青蒿素的半合成衍生物,青蒿素是中草药青蒿的活性化合物,由去氢青蒿素3的琥珀酸钠盐组成。青蒿素类化合物比任何其他已知的抗疟疾药物都能更快地降低疟疾寄生虫血症,并且有效抵抗多种药物耐药的疟疾寄生虫4,5。青蒿琥酯对恶性疟原虫的多药耐药菌株非常有效,因此其在疟疾的治疗和管理中的用途越来越广泛6。青蒿琥酯在治疗剂量下耐受性良好;因此,很多人,包括孕妇在内都服用该药。几项研究表明,大剂量青蒿琥酯可产生神经毒性,例如对小鼠和大鼠脑干中枢的选择性损伤7、8、9。青蒿琥酯据报道会引起动物步态紊乱,脊髓丧失和疼痛反应机制[10,11]。胃是位于腹腔的可扩张器官,在体内降解和消化食物。由于大量粘液分泌腺的存在,它还可以防止胃溃疡12。青蒿琥酯对胃的影响可能尚未被证实,但是有报道称它可能与恶心,呕吐,腹泻和腹痛的各种症状有关。本研究旨在阐明青蒿琥酯对胃的组织学作用

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号